Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
4
×
san diego top stories
boston blog main
boston top stories
fda
national top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
messenger rna
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
acute myeloid leukemia
ad-comm
adverum biotechnologies
affimed
akcea therapeutics
allogene therapeutics
What
million
4
×
therapeutics
4
×
ipo
new
raised
cancer
drug
allogene
athena
bio
biotech
biotechs
brings
ceo
chief
club
companies
company
continued
countouriotis
crispr
crop
developing
disorders
diversity
dyne
dyne’s
exceeded
financing
firms
genetic
gets
group
haul
hot
immunotherapy
investors
joined
juno
latest
Language
unset
Current search:
therapeutics
×
million
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M